Acevaltrate

CAS No. 25161-41-5

Acevaltrate ( —— )

Catalog No. M18309 CAS No. 25161-41-5

Acevaltrate displays high cytotoxicity against GLC(4), a human small-cell lung cancer cell line, and against COLO 320, a human colorectal cancer cell line, with IC50 values of 1-6 uM.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 80 In Stock
10MG 125 In Stock
25MG 250 In Stock
50MG 397 In Stock
100MG 584 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Acevaltrate
  • Note
    Research use only, not for human use.
  • Brief Description
    Acevaltrate displays high cytotoxicity against GLC(4), a human small-cell lung cancer cell line, and against COLO 320, a human colorectal cancer cell line, with IC50 values of 1-6 uM.
  • Description
    Acevaltrate displays high cytotoxicity against GLC(4), a human small-cell lung cancer cell line, and against COLO 320, a human colorectal cancer cell line, with IC50 values of 1-6 uM.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    25161-41-5
  • Formula Weight
    480.51
  • Molecular Formula
    C24H32O10
  • Purity
    98%
  • Solubility
    DMSO : ≥ 125 mg/mL; 260.15 mM
  • SMILES
    CC(C)CC(=O)OC1C2C(=CC(C23CO3)OC(=O)CC(C)(C)OC(=O)C)C(=CO1)COC(=O)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 5-bromo-2-(2,6-dioxo...

    5-bromo-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione is a chemical compound.

  • Vazegepant HCl

    Vazegepant is the first intranasal gepant for the acute treatment of migraine and has announced a positive phase II/III study.

  • Mal-PEG2-C2-Boc

    Mal-PEG2-C2-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.